386 related articles for article (PubMed ID: 28375009)
21. Multicomponent reactions in drug discovery and medicinal chemistry.
Ruijter E; Orru R;
Drug Discov Today Technol; 2018 Nov; 29():1-2. PubMed ID: 30471667
[No Abstract] [Full Text] [Related]
22. Overview of chemical diversity.
Triggle DJ
Curr Protoc Pharmacol; 2001 May; Chapter 9():Unit 9.1. PubMed ID: 21971814
[No Abstract] [Full Text] [Related]
23. The Most Common Functional Groups in Bioactive Molecules and How Their Popularity Has Evolved over Time.
Ertl P; Altmann E; McKenna JM
J Med Chem; 2020 Aug; 63(15):8408-8418. PubMed ID: 32663408
[TBL] [Abstract][Full Text] [Related]
24. Risk Management in Early Discovery Medicinal Chemistry.
Singh G; Dahlin JL; Walters MA
Methods Enzymol; 2018; 610():1-25. PubMed ID: 30390795
[TBL] [Abstract][Full Text] [Related]
25. Bluegenics: Bioactive Natural Products of Medicinal Relevance and Approaches to Their Diversification.
Zarins-Tutt JS; Abraham ER; Bailey CS; Goss RJ
Prog Mol Subcell Biol; 2017; 55():159-186. PubMed ID: 28238038
[TBL] [Abstract][Full Text] [Related]
26. March of the synthesis machines.
Sanderson K
Nat Rev Drug Discov; 2015 May; 14(5):299-300. PubMed ID: 25924572
[No Abstract] [Full Text] [Related]
27. The convergence of artificial intelligence and chemistry for improved drug discovery.
Green CP; Engkvist O; Pairaudeau G
Future Med Chem; 2018 Nov; 10(22):2573-2576. PubMed ID: 30499699
[No Abstract] [Full Text] [Related]
28. A data mining method to facilitate SAR transfer.
Wassermann AM; Bajorath J
J Chem Inf Model; 2011 Aug; 51(8):1857-66. PubMed ID: 21774471
[TBL] [Abstract][Full Text] [Related]
29. Designing active template molecules by combining computational de novo design and human chemist's expertise.
Lameijer EW; Tromp RA; Spanjersberg RF; Brussee J; Ijzerman AP
J Med Chem; 2007 Apr; 50(8):1925-32. PubMed ID: 17367122
[TBL] [Abstract][Full Text] [Related]
30. Early phase drug discovery: cheminformatics and computational techniques in identifying lead series.
Duffy BC; Zhu L; Decornez H; Kitchen DB
Bioorg Med Chem; 2012 Sep; 20(18):5324-42. PubMed ID: 22938785
[TBL] [Abstract][Full Text] [Related]
31. Editorial: in silico drug design and medicinal chemistry).
Singla RK
Curr Top Med Chem; 2015; 15(11):971-2. PubMed ID: 25860175
[TBL] [Abstract][Full Text] [Related]
32. Stabilization of protein-protein interactions in drug discovery.
Andrei SA; Sijbesma E; Hann M; Davis J; O'Mahony G; Perry MWD; Karawajczyk A; Eickhoff J; Brunsveld L; Doveston RG; Milroy LG; Ottmann C
Expert Opin Drug Discov; 2017 Sep; 12(9):925-940. PubMed ID: 28695752
[TBL] [Abstract][Full Text] [Related]
33. Greener and sustainable approaches to the synthesis of pharmaceutically active heterocycles.
Polshettiwar V; Varma RS
Curr Opin Drug Discov Devel; 2007 Nov; 10(6):723-37. PubMed ID: 17987524
[TBL] [Abstract][Full Text] [Related]
34. Open-access high-resolution mass spectrometry in early drug discovery.
Thomas SR; Gerhard U
J Mass Spectrom; 2004 Aug; 39(8):942-8. PubMed ID: 15329846
[TBL] [Abstract][Full Text] [Related]
35. The importance of synthetic chemistry in the pharmaceutical industry.
Campos KR; Coleman PJ; Alvarez JC; Dreher SD; Garbaccio RM; Terrett NK; Tillyer RD; Truppo MD; Parmee ER
Science; 2019 Jan; 363(6424):. PubMed ID: 30655413
[TBL] [Abstract][Full Text] [Related]
36. Transforming fragments into candidates: small becomes big in medicinal chemistry.
de Kloe GE; Bailey D; Leurs R; de Esch IJ
Drug Discov Today; 2009 Jul; 14(13-14):630-46. PubMed ID: 19443265
[TBL] [Abstract][Full Text] [Related]
37. High-throughput development of amphiphile self-assembly materials: fast-tracking synthesis, characterization, formulation, application, and understanding.
Mulet X; Conn CE; Fong C; Kennedy DF; Moghaddam MJ; Drummond CJ
Acc Chem Res; 2013 Jul; 46(7):1497-505. PubMed ID: 23427836
[TBL] [Abstract][Full Text] [Related]
38. Into the Fray! A Beginner's Guide to Medicinal Chemistry.
Veale CGL
ChemMedChem; 2021 Apr; 16(8):1199-1225. PubMed ID: 33591595
[TBL] [Abstract][Full Text] [Related]
39. Cell-based medicinal chemistry optimization of high throughput screening hits for orally active antimalarials. Part 2: hits from SoftFocus kinase and other libraries.
Younis Y; Street LJ; Waterson D; Witty MJ; Chibale K
J Med Chem; 2013 Oct; 56(20):7750-4. PubMed ID: 23927599
[TBL] [Abstract][Full Text] [Related]
40. An overview of late-stage functionalization in today's drug discovery.
Moir M; Danon JJ; Reekie TA; Kassiou M
Expert Opin Drug Discov; 2019 Nov; 14(11):1137-1149. PubMed ID: 31411499
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
